| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2015 | PRGO Perrigo Co Plc | Farrington Thomas | EVP And CIO | Sell | 350 | $151.03 | $52,860.50 | -22.7% | |
| Nov 25, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barrett M James | Director | Sell | 16,179 | $16.35 | $264,494.29 | -18.0% | |
| Nov 24, 2015 | PAHC Phibro Animal Health Corp | Dagger Thomas G | SVP, Gen Counsel &Corp Sec | Sell | 4,000 | $32.87 | $131,480.00 | -100% | |
| Nov 24, 2015 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 16,000 | $32.08 | $513,280.00 | -100% | |
| Nov 24, 2015 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 22,733 | $6.79 | $154,434.40 | +13.4% | |
| Nov 20, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $84.54 | $17,331,231.40 | - | |
| Nov 20, 2015 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 3,000 | $60.00 | $180,000.00 | -51.3% | |
| Nov 20, 2015 | JNJ Johnson & Johnson | Ullmann Michael H | VP, General Counsel | Sell | 17,650 | $102.47 | $1,808,542.55 | -18.6% | |
| Nov 20, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 31,529 | $14.29 | $450,511.58 | -35.5% | |
| Nov 19, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 17,871 | $37.50 | $670,162.50 | -1.0% | |
| Nov 19, 2015 | PRGO Perrigo Co Plc | Gottfried Ran | Director | Sell | 2,726 | $154.34 | $420,721.86 | -6.2% | |
| Nov 19, 2015 | CPIX Cumberland Pharmaceuticals Inc | Lawrence Thomas R | Director | Sell | 4,000 | $5.61 | $22,440.00 | -7.4% | |
| Nov 18, 2015 | PRGO Perrigo Co Plc | Morris Herman Jr | Director | Sell | 550 | $155.64 | $85,602.00 | -39.3% | |
| Nov 18, 2015 | TLPH Talphera, Inc. | Perceptive Advisors LLC51 | 10% Owner | Sell | 176,200 | $5.35 | $943,540.99 | -1.4% | |
| Nov 18, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barrett M James | Director | Sell | 93,000 | $16.61 | $1,545,003.00 | -68.4% | |
| Nov 18, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $31.63 | $379,560.00 | -5.4% | |
| Nov 18, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $31.63 | $379,560.00 | -5.4% | |
| Nov 18, 2015 | ELTP Elite Pharmaceuticals Inc /nv/ | Treppel Jerry | Chairman Of Board | Sell | 150,000 | $0.30 | $45,252.50 | -0.4% | |
| Nov 17, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 3,772 | $13.95 | $52,606.20 | -11.5% | |
| Nov 16, 2015 | SNY Sanofi | Sanofi | Former 10% Owner | Buy | 125,000 | $14.00 | $1,750,000.00 | +5.3% | |
| Nov 16, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barrett M James | Director | Sell | 119,650 | $16.24 | $1,942,645.07 | -36.8% | |
| Nov 13, 2015 | EBS Emergent Biosolutions Inc. | Labinger Barry | EVP, Biosciences Div. | Sell | 3,376 | $36.50 | $123,224.00 | -11.8% | |
| Nov 13, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 13,013 | $36.50 | $474,974.50 | -0.7% | |
| Nov 12, 2015 | ANIP Ani Pharmaceuticals Inc | Przybyl Arthur | President And CEO | Buy | 2,500 | $40.95 | $102,375.00 | +1.8% | |
| Nov 12, 2015 | EBS Emergent Biosolutions Inc. | Labinger Barry | EVP, Biosciences Div. | Sell | 36,126 | $35.64 | $1,287,585.64 | -23.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.